Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Inhibition of the transcription factor Sp1 suppresses colon cancer stem cell growth and induces apoptosis in vitro and in nude mouse xenografts.

Zhao Y, Zhang W, Guo Z, Ma F, Wu Y, Bai Y, Gong W, Chen Y, Cheng T, Zhi F, Zhang Y, Wang J, Jiang B.

Oncol Rep. 2013 Oct;30(4):1782-92. doi: 10.3892/or.2013.2627. Epub 2013 Jul 18.

PMID:
23877322
2.

Krüppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells.

Leng Z, Tao K, Xia Q, Tan J, Yue Z, Chen J, Xi H, Li J, Zheng H.

PLoS One. 2013;8(2):e56082. doi: 10.1371/journal.pone.0056082. Epub 2013 Feb 13.

3.

CD49f-positive cell population efficiently enriches colon cancer-initiating cells.

Haraguchi N, Ishii H, Mimori K, Ohta K, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Yamamoto H, Doki Y, Mori M.

Int J Oncol. 2013 Aug;43(2):425-30. doi: 10.3892/ijo.2013.1955. Epub 2013 May 24.

PMID:
23708747
4.

Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.

Wang C, Xie J, Guo J, Manning HC, Gore JC, Guo N.

Oncol Rep. 2012 Oct;28(4):1301-8. doi: 10.3892/or.2012.1951. Epub 2012 Aug 6.

5.

High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells.

Puglisi MA, Cenciarelli C, Tesori V, Cappellari M, Martini M, Di Francesco AM, Giorda E, Carsetti R, Ricci-Vitiani L, Gasbarrini A.

J Pathol. 2015 Aug;236(4):479-90. doi: 10.1002/path.4545. Epub 2015 May 12.

PMID:
25875314
6.

CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.

Muraro MG, Mele V, Däster S, Han J, Heberer M, Cesare Spagnoli G, Iezzi G.

Stem Cells Transl Med. 2012 Aug;1(8):592-603. doi: 10.5966/sctm.2012-0003. Epub 2012 Aug 6.

7.

Epigenetic regulation of CD133/PROM1 expression in glioma stem cells by Sp1/myc and promoter methylation.

Gopisetty G, Xu J, Sampath D, Colman H, Puduvalli VK.

Oncogene. 2013 Jun 27;32(26):3119-29. doi: 10.1038/onc.2012.331. Epub 2012 Sep 3.

8.

Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.

Wang D, Fu L, Sun H, Guo L, DuBois RN.

Gastroenterology. 2015 Dec;149(7):1884-1895.e4. doi: 10.1053/j.gastro.2015.07.064. Epub 2015 Aug 7.

9.

Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.

Botchkina IL, Rowehl RA, Rivadeneira DE, Karpeh MS Jr, Crawford H, Dufour A, Ju J, Wang Y, Leyfman Y, Botchkina GI.

Cancer Genomics Proteomics. 2009 Jan-Feb;6(1):19-29.

10.

CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma.

Shi C, Tian R, Wang M, Wang X, Jiang J, Zhang Z, Li X, He Z, Gong W, Qin R.

Cancer Biol Ther. 2010 Dec 1;10(11):1182-90. Epub 2010 Dec 1.

PMID:
20948317
11.

Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells.

Oh PS, Patel VB, Sanders MA, Kanwar SS, Yu Y, Nautiyal J, Patel BB, Majumdar AP.

Am J Physiol Gastrointest Liver Physiol. 2011 Aug;301(2):G347-55. doi: 10.1152/ajpgi.00403.2010. Epub 2011 May 19.

12.

CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.

Feng BH, Liu AG, Gu WG, Deng L, Cheng XG, Tong TJ, Zhang HZ.

Oncol Rep. 2013 Aug;30(2):815-23. doi: 10.3892/or.2013.2486. Epub 2013 May 23.

PMID:
23708735
13.

Plasma membrane proteomics of tumor spheres identify CD166 as a novel marker for cancer stem-like cells in head and neck squamous cell carcinoma.

Yan M, Yang X, Wang L, Clark D, Zuo H, Ye D, Chen W, Zhang P.

Mol Cell Proteomics. 2013 Nov;12(11):3271-84. doi: 10.1074/mcp.M112.025460. Epub 2013 Jul 31.

14.

Identification of stem-like cells and clinical significance of candidate stem cell markers in gastric cancer.

Zhang X, Hua R, Wang X, Huang M, Gan L, Wu Z, Zhang J, Wang H, Cheng Y, Li J, Guo W.

Oncotarget. 2016 Mar 1;7(9):9815-31. doi: 10.18632/oncotarget.6890.

15.

Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1.

Bao B, Azmi AS, Aboukameel A, Ahmad A, Bolling-Fischer A, Sethi S, Ali S, Li Y, Kong D, Banerjee S, Back J, Sarkar FH.

J Biol Chem. 2014 May 23;289(21):14520-33. doi: 10.1074/jbc.M113.532887. Epub 2014 Apr 9.

16.

FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.

Song IS, Jeong YJ, Jeong SH, Heo HJ, Kim HK, Bae KB, Park YH, Kim SU, Kim JM, Kim N, Ko KS, Rhee BD, Han J.

Gastroenterology. 2015 Oct;149(4):1006-16.e9. doi: 10.1053/j.gastro.2015.06.007. Epub 2015 Jun 17.

PMID:
26091938
17.

LGR5 is required for the maintenance of spheroid-derived colon cancer stem cells.

Chen X, Wei B, Han X, Zheng Z, Huang J, Liu J, Huang Y, Wei H.

Int J Mol Med. 2014 Jul;34(1):35-42. doi: 10.3892/ijmm.2014.1752. Epub 2014 Apr 24.

18.

Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery.

Fang DD, Kim YJ, Lee CN, Aggarwal S, McKinnon K, Mesmer D, Norton J, Birse CE, He T, Ruben SM, Moore PA.

Br J Cancer. 2010 Apr 13;102(8):1265-75. doi: 10.1038/sj.bjc.6605610. Epub 2010 Mar 23.

19.

Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor.

Huang R, Wang G, Song Y, Tang Q, You Q, Liu Z, Chen Y, Zhang Q, Li J, Muhammand S, Wang X.

Mol Med Rep. 2015 Aug;12(2):2417-24. doi: 10.3892/mmr.2015.3694. Epub 2015 Apr 28.

20.

Betulinic acid decreases specificity protein 1 (Sp1) level via increasing the sumoylation of sp1 to inhibit lung cancer growth.

Hsu TI, Wang MC, Chen SY, Huang ST, Yeh YM, Su WC, Chang WC, Hung JJ.

Mol Pharmacol. 2012 Dec;82(6):1115-28. doi: 10.1124/mol.112.078485. Epub 2012 Sep 5.

Supplemental Content

Support Center